GENOMIC VISION news, videos and press releases - Page 2
For more news please use our advanced search feature.
GENOMIC VISION - More news...
GENOMIC VISION - More news...
- Genomic Vision Announces New Financing Line with Winance, Subject to Prior Approval of the Company's Shareholders
- Genomic Vision’s Technology is Acquired by Department of Cell Biology, Microbiology & Molecular Biology at the University of South Florida to Study Mechanisms of DNA Replication and Replication Stress
- Genomic Vision: Financial Information for the Fourth Quarter of 2021
- Genomic Vision Announces the Issuance of 2 New Tranches of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million
- Genomic Vision: Financial Information for the Third Quarter of 2021
- Genomic Vision Announces TeloSizer® Triathlon Program to Provide Academic Researchers With an Access Path to Molecular Combing Telomere Services
- Genomic Vision Strengthens Its Leadership Team With the Appointment of Thierry HUET as R&D Director
- Genomic Vision Launches TeloSizer® for Precise Detection and Quantitative Measurement of Telomere Length
- Genomic Vision: First-half 2021 Results
- Genomic Vision Expands Its Services Offering to Fulfill the Demands For DNA Replication Analysis for Drug Discovery in Cancer Treatment
- Genomic Vision Announces the Issuance of 2 New Tranches of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million
- Genomic Vision: New Ordinary General Meeting to Be Held on June 30, 2021
- Genomic Vision Announces Early Access Program for a New Detection Suite Based on Innovative Artificial Intelligence Technology
- Genomic Vision: Financial Information for the First Quarter of 2021
- Genomic Vision Announce the Pursuit of Its Partnership With Sanofi and the Successful Completion of Its First Milestone
- Genomic Vision: 2020 Annual Results
- Genomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director
- Genomic Vision Announces the Issuance of the 2nd Tranche of Convertible Notes With Warrants (OCABSA) for €1.2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million
- Genomic Vision: Financial Information for the Fourth Quarter of 2020
- Genomic Vision Announces the Availability of the Prospectus Relating to the Financing Program Concluded With Winance for a Maximum Amount of €12 Million
- As Part of the Financing Line Concluded With Winance, Genomic Vision Announces the Issuance of the First Tranche of Convertible Notes With Warrants (OCABSA) for €0.8 Million
- Genomic Vision: Financial Information for the Third Quarter of 2020
- Genomic Vision Signs a Distribution Agreement for Covid-19 Rapid Diagnostic Tests With Toda Pharma
- Genomic Vision: First-half 2020 Results
- Genomic Vision: Convening of Another Extraordinary General Meeting on October 30, 2020
- Genomic Vision Announces the Approval by its General Meeting of all the Resolutions Recommended by the Management Board
- Genomic Vision: Convening of a New Combined Shareholders’ Meeting on August 10, 2020
- Genomic Vision: Financial Information for the First Half of 2020
- Genomic Vision: Implementation of a Financing Line via the Reserved Issuance of Convertible Notes With Warrants (OCABSA) for a Maximum of €12 Million, Subject to Shareholders’ Approval
- Genomic Vision: Financial Information for the First Quarter of 2020
